Publications database

Displaying 31 - 40 of 42

Implementation reports

EMCDDA–Europol 2008 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2008. In 2008, 13 new psychoactive substances were officially notified...

Implementation reports

EMCDDA–Europol 2007 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2007. In 2007, 15 new psychoactive substances were officially notified...

Manuals and guidelines

Early-warning system on new psychoactive substances — operating guidelines

These practical guidelines have been published to assist the implementation of the Council decision on information exchange, risk-assessment and control of new psychoactive substances. They deal with phase 1 of the measures...

Implementation reports

EMCDDA–Europol 2006 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2007. In 2006, 7 new psychoactive substances were officially notified...

Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP)

In December 2006, after examining the available information collected on BZP (1-benzylpiperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint Report. Pursuant to the findings...

Implementation reports

EMCDDA–Europol 2005 Annual Report on the implementation of Council Decision 2005/387/JHA

The report outlines the results of the implementation of the Council Decision in 2005 and describes some issues arising from the initial experiences. In 2005, 14 new psychoactive substances were officially notified...

Risk assessments

Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs

The risk-assessment reports on the synthetic drugs 2C-I; 2C-T-2 and 2C-T-7 were submitted by the EMCDDA to the European Council and Commission on 4 April 2003. The reports were drawn up at...

Risk assessments

Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs

The risk-assessment report on the synthetic drug TMA-2 was submitted by the EMCDDA to the European Council and Commission on 4 April 2003. The report was drawn up at a meeting in...

Risk assessments

Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs

The report assesses the risks of PMMA, especially in association with the already controlled substance PMA (para-methoxyamphetamine). PMMA, is an amphetamine-like substance very close to PMA, and is almost exclusively sold in...

Risk assessments

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

Since the mid-1990s, GHB – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Some EU countries have reported worries over GHB’s surreptitious...